ABSTRACT BACKGROUND: Oxytocin is a neuropeptide affecting social behaviour. Autism spectrum disorders are characterized by social defi cits, impaired communication and repetitive behaviours. Several studies have shown reduced plasma levels of oxytocin and moreover, administration of oxytocin reduced clinical symptoms of autism. AIM: The aim of this study was to reveal differences in the plasma levels of oxytocin between autistic and healthy populations in Slovakia. METHODS: After a signed consent, 108 autism spectrum disorder patients were enrolled in the study (83 males, 25 females). A control group of 131 healthy children was recruited (106 males, 25 females). Blood samples were obtained from all children and plasma oxytocin levels were measured using the ELISA method. RESULTS: Oxytocin levels were lower in the boys older than 10 years of age in comparison to controls. There were no signifi cant differences in oxytocin levels among girls. Oxytocin levels did not signifi cantly correlate with age in either of the examined groups. CONCLUSION: Decreased oxytocin levels in plasma of autism boys may be related to decreased sociability and social interactions. The addition of psychological profi ling may reveal possible correlations of hormone levels with symptom severities (Tab. 1, Fig. 2 Acknowledgements: Authors thank all the families with autism and control group children for their participation. Study was supported by the following grants: APVV-0253-10, APVV-0254-11, VEGA-1/0066/12.
Introduction
Oxytocin is a neuropeptide widely distributed in the central nervous system, promoting a high variety of effects on brain functions. Animal studies show that oxytocin plays a role in social interactions, attachment, pair bonding, sexual behaviour and social memory (1) . Oxytocin knockout mice display social defi cits such as impaired social recognition (2) . Oxytocin receptor knockouts display defi cits in ultrasonic vocalization in response to maternal separation in comparison to control mice (3) .
Human studies confi rm these prosocial characteristics of oxytocin observed in animal models. Oxytocin was found to improve several aspects of human social behaviour such as interpersonal trust (4), eye contact (5), and empathy measured as the ability to infer mental states of others (6) .
Autism spectrum disorders (ASD) are characterized by social defi cits, impaired communication and repetitive behaviours. Defi cits in social behaviour are a core symptom of autism that makes an oxytocin system a major suspect in the pathogenesis of the disorder.
Several studies have shown altered plasma levels of oxytocin. Modahl et al (7) found reduced oxytocin levels in 29 pre-pubertal boys with autism compared to 30 age-matched controls in the US population. Green et al (8) have extended this study and have found an alteration in oxytocin peptide processing in this sample. Oxytocin plasma levels were decreased and levels of oxytocin Cterminal extended peptides were increased in autistic boys compared to healthy subjects. Oxytocin and vasopressin levels were found to be reduced in 77 autistic boys from central Saudi Arabia compared to the controls (9). Andari et al (10) found profoundly decreased oxytocin levels in 13 high functioning autistic patients compared to controls in a French population. Finally, a study focusing on peripheral neuropeptide levels revealed no differences in oxytocin and vasopressin levels among 75 autistic patients compared to age-matched controls in the US population (11) .
In the last few years, a number of studies employing oxytocin administration in the treatment of mental illnesses emerged rapidly. Intranasal and intravenous oxytocin administration was shown to improve some of the clinical symptoms of autism, such as repetitive behaviours (12) , increased social learning (13), increased social recognition and emotionality (14, 15) , and improved social interaction in high functioning autistic patients (10) .
Underlying the link between oxytocin and autism, the number of genetic studies have shown positive associations among polymorphism in genes encoding oxytocin and oxytocin receptors and autism employing family or population based approaches (16) (17) (18) (19) (20) (21) .
The aim of the present study was to reveal differences in the plasma levels of oxytocin among autistic and healthy population in Slovakia.
Methods
The study was approved by the Ethical Committee at Faculty of Medicine, Comenius University in Bratislava.
After acquiring an informed consent, 108 autistic patients were enrolled into the study (83 males, 25 females). Boys were aged from: 2 years to 22 years (mean age 7 ± 5 years) and girls were aged from 2 to 22 years (mean age 7 ± 6 years). 131 healthy children (106 males, 25 females) were recruited as a control group. Boys in the control group were aged from 2 to 20 years (mean age 11 ± 6 years) and girls in the control group were aged from 2 to 25 years (mean age 10 ± 8 years). The diagnosis of childhood autism was assessed by a psychiatristand clinical psychologist using the standard protocols (ICD-10, DSM-IV).
Blood samples were obtained from all children and the plasma oxytocin levels were measured using the ELISA method (Enzo Life Sciences). Differences in the oxytocin levels were evaluated using the unpaired t-test. Correlations of the plasma oxytocin levels with age were assessed using the Pearson correlation test.
Results
Children were divided into the groups according to age and gender; boys into the two groups (under 10 years and above 10 years).
The oxytocin levels were lower in the group of all boys, especially in the boys above 10 years of age, in comparison to controls (Tab. 1, Fig. 1 ). There were no signifi cant differences in oxytocin levels among girls (Tab. 1, Fig. 2 ). The oxytocin levels did not signifi cantly correlate with age in either of the examined groups. Autistic and control girls had higher oxytocin levels than boys, however, the differences were not signifi cant (data not shown).
Discussion
In the present study, we have found decreased plasma oxytocin levels in boys with the diagnosis of autism in Slovakia compared to age-matched healthy controls. This signifi cant difference emerged mostly due to reduced oxytocin levels in boys above ten years of age. However, we have not found any correlations of the oxytocin levels with age in any of the groups examined. Our results confi rm results of the previous studies, which have found reduced plasma oxytocin levels in autistic boys (7) (8) (9) (10) .
Reduced oxytocin levels may explain profound social defi cits, a core symptom of autism. However, peripheral peptide levels can hardly refl ect brain oxytocin levels, expression, distribution and binding affi nities of oxytocin receptors in the brain, which may be crucial for promoting prosocial effects of the oxytocin.
Reduction of the oxytocin levels may be due to lower oxytocin expression determined genetically. Other possibilities involve changes in enzymes involved in oxytocin synthesis or metabolism of oxytocin, which may be relevant in ASD pathogenesis (22).
We have found no differences in oxytocin levels in girls, possibly due to relatively small sample size. Girls had higher levels of plasma oxytocin than boys, however, the difference did not reach statistically signifi cant levels. Other studies suggest a trend to increased plasma oxytocin levels in females (23). Expression of the oxytocin and its receptor is estrogen dependent, suggesting sex differences on the oxytocin system in humans (22). Active mechanisms employing estrogens together with the oxytocin and the oxytocin receptors may provide a protective milieu partially explaining the lower incidence of autism spectrum disorders in females.
Still increasing number of studies show that ASD is a complex condition involving many altered mechanisms. It is, therefore, probable that different autism traits may have several aetiologies. Profound social defi cits are a core symptom in all ASD patients. Several studies have shown a correlation of social defi cits with the oxytocin system, i.e. polymorphisms in the oxytocin receptor gene and/or altered plasma oxytocin levels (7, 20) . Moreover, these social defi cits seem to be at least partially improved after oxytocin administration in autistic patients (10, (13) (14) (15) . A limitation of the present study is an absence of behavioural data in autistic patients. The addition of psychological profi ling may reveal possible correlations of oxytocin levels with symptom manifestation and symptom severities in the children with autism in Slovakia.
